Tag | Content |
---|
EnhancerAtlas ID | HS197-12267 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr2:182740340-182742660 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Atoh1 | MA0461.2 | chr2:182742594-182742604 | AACATATGTT | + | 6.02 | Atoh1 | MA0461.2 | chr2:182742594-182742604 | AACATATGTT | - | 6.02 | Mafb | MA0117.2 | chr2:182740467-182740479 | TGTCAGCATATT | - | 6.11 | REL | MA0101.1 | chr2:182740844-182740854 | GGAAATCCCC | - | 6.02 | ZNF263 | MA0528.1 | chr2:182741053-182741074 | TCCTCCTTCCACTAATCCTCC | - | 6.41 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_34317 | chr2:182740128-182742809 | HCT-116 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I181875 | chr2 | 182740453 | 182742501 |
|
Enhancer Sequence | CACTGAAATC TGAATTTTGG AAAAACAATG CATAATTTTA AGGTGCATCC CATGCAATAC 60 TATTTGTTAT CTAAAACTGG TATTTAACTG GATGCCCTGC ATTTCTGTTT TCCAAATGTG 120 GGAACCTTGT CAGCATATTG GTTTATCTTC TTAGGCCAGC CTCTCTCATG GCCACGAGAT 180 GGCTGCCATA GCTCTTAGTG TTATGTGAAG ATGCCAATAT CCACTGGCAT AAAAGTGATT 240 CTTTTGGTAA AGAAGAAGGT GGAGGAATGG TGGTTTGATA GCTAACCAAC AATATAAATC 300 ACCAAGGCAA ATCTGATTTT TTGTTGATTA AAACATAGTT TCTGCCAATA TTAAGTACTT 360 AGTTCTGTAA CAGGATATAA TTTACCCTGC CTTCTGATTT AAGGACAGAA AGTTATCGAC 420 TGTAGTATTT ATGTAGAAGT TTCTGGCCCT TATTTTTCTT CTGTGAAAAT GTATATTTTG 480 TTTTGAGACT CTTTGTTAGA TCTGGGAAAT CCCCTATCAC TGAATCTGAA ATAATTTTCA 540 TTGAGACTGA AATGAGGGAA GGAGACGGCT CATTTGCAGT TTCCCCTTTT CCACAATATT 600 CCCGGGGCAC ATAGTAAGCA GTTCTCCATG TTCATCATTC TTTTCTCCTC CCTTATATGT 660 TAGTTGTTCA CATTACCCCT AGCCAAATTC CATCTTAATT TTCCATGTTC CCTTCCTCCT 720 TCCACTAATC CTCCTTTTAA AATGTGTCTT TATCTTCAGG CCCCTATTTA TACTTAAGTG 780 ATAATGATTT TAAATGGGCT GAACTAATCT GTGTTAATAT TACTATATTA ATATTACTGT 840 GTTAATATTT ACTTTGTTAA TGTGTTGGAC CTCTGGGGTA ATTTAAGCCT TTTATCATTT 900 CAAAAGTTCA ACCCCGTTAA AAAGCTCTTC AGGAATGCTG CCAGTTTGGG CACCTTAGTG 960 GCACAGCACT TTTGGCTTCC CCATCAAGCT CAGAGAGGTA GGTGACTAAA AGAAAGAGAG 1020 GCCTGTATGA CTGCTCTCTG CAGTCTGTTC ATCATGGCTG TCTGGTCTCT GTACTTACTT 1080 TATCTTAGAT TATTCTCTCA TCAGACTCAC ACTGCAATCC ACTGGTCTCT GAAGTCCTTT 1140 TCTCCACCCC TTCCTGTCTC ATCCTGAGTG ATTCATCTGT GACTTCAGTA TTTATAGGGA 1200 TGCCCCACCC AGCACCCTAG ACTCATAATT TCTTGACCTC CTCTTCTACA GAGGCTTTTA 1260 ATGCCTTTGG ACGTCAGTGT TCTCCCAGTG CCACACCCCA GTGCTACCTA GTCATCCAGT 1320 AATTCTTCAC CTCCTACAAT TACACTTCAA AATCCTGTGT TGCAATCTAA GCTCCTGCCC 1380 CTTTCAACGA TCTTACTGCC CCTTACTTCT ATCAGGCTAG CCCACTGACC TCATAAGGAA 1440 TTTAAAACCT TAGGAAAATA GCAAAGAACC AAGTATTTGA GCGCCTCTAC AAACCCACTT 1500 GCTTCACTCC TGCCTTCTCT CTTCCAAGCA GTCTGCACTC TGTGGATTAT CTCAACAACT 1560 AAGCCCTCAT TTTCCTCCAT ATCTCGAACT TCTATCACAT TCAACCTCTG AACTCCTATC 1620 CTGGATGAAT CTTAAAACAT TGGTCTTTTG AAATTCAACA CCTATGTACC TAAATCTGCT 1680 TAATAAACTC ATATCATTGA CATGTGGGCC TTTTAGAATG TTGAACAATT AGGAGGCAGC 1740 ATTGCAAAGT GGTTCAGAGC ATGAAGCTCA GTTCCTGGCT CCTCCACTAG CTGAGTGCCT 1800 TTGGGAAAAT AGCATGACCA CTTTGTGCCT GATTTTCTTC TTCTGCAAAA AGAATAATTG 1860 AACATATCTC ACAGGTATGT TACTGTGAGC AAACGAGTTA ATCTTTACAA GGTGCTTAAC 1920 TGTTGAATAA ATGAATATTT TACTGCTTCC TTGTAGTTTT ATTTCCATTT TGAATAATAG 1980 CTATTCAAAA TCTTTACCCT TTTAAGTTAT CCAAACAGCT CAGGCTCCAT CACTTCAGCA 2040 GATTATCTGG CCTAGTTCTT AGAATACATA TAGGACATTA GGTGTGAATG CATTTAAATT 2100 ATCTCCCCCT GAAAATTTAA GCACATTGGT GCATTTATAT CTCCTTTCCA TCTAAAAAAA 2160 GACCTTCTAA AGTTAATTTT TTTCTTCTTC TCCTCAAGAT CTTATCTTTT CAAATATCTA 2220 ACCTGTCTTT ATTTGTTCCT GTCTTTAGCT AATAAACATA TGTTATTCCC ATGTATCCCT 2280 GACAAAAAAT AATAAAAAAT CCTTTTTCAA TCATACATTT 2320
|